Care/of vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Personalized vitamin subscription brand acquired by Bayer for $225M in 2020; continues as digital-native supplement label under Bayer Consumer Health.
About
Care/of is a New York-based personalized vitamin and supplement brand founded in 2016 by Craig Elbert and Akash Shah. The company popularized algorithm-driven supplement personalization, asking consumers a series of lifestyle and health questions to recommend a custom daily vitamin pack delivered by subscription. Care/of was acquired by Bayer in November 2020 at a $225 million valuation, giving Bayer a majority ownership stake in the direct-to-consumer brand.\n\nUnder Bayer's Consumer Health division, Care/of has continued to operate with its original DTC model and brand identity while leveraging Bayer's supply chain, clinical validation resources, and marketing infrastructure. The brand extended its product line to include protein powders, collagen supplements, and wellness shots, maintaining its personalization-first positioning in a crowded supplement market.\n\nCare/of targets millennial consumers who value personalized wellness plans and want evidence-cited ingredient explanations. The brand's website provides research citations for every recommended ingredient, a transparency approach that built early credibility and loyalty. As part of Bayer, Care/of benefits from credentialing by association with a global pharmaceutical brand while retaining its digital-native identity.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.